Current Drug Targets


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Meet the Editorial Board: free to download

Volume:16   Issue: 2
Pp: 93-93
Manuel S. Yepes
DOI: 10.2174/138945011602150209144043
Published on: 09 February, 2015

Editorial (Mini-Thematic Issue: Morphological and Molecular Backgrounds for Personalized Therapies in Genitourinary Cancers) free to download

Volume:16   Issue: 2
Pp: 94-95
Rodolfo Montironi, Marina Scarpelli, Matteo Santoni, Antonio Lopez-Beltran and Liang Cheng
DOI: 10.2174/138945011602150209144413
Published on: 09 February, 2015

Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview

Volume:16   Issue: 2
Pp: 96-102
Rodolfo Montironi, Matteo Santoni, Antonio Lopez-Beltran, Liang Cheng, Holger Moch and Marina Scarpelli
DOI: 10.2174/1389450115666141202113805
Published on: 09 February, 2015

Molecular Foundations for Personalized Therapy in Prostate Cancer

Volume:16   Issue: 2
Pp: 103-114
Kurt W. Fisher, Rodolfo Montironi, Antonio Lopez Beltran, Holger Moch, Lisha Wang, Marina Scarpelli, Sean R. Williamson, Michael O. Koch and Liang Cheng
DOI: 10.2174/1389450115666141229154500
Published on: 09 February, 2015

Bladder Cancer: Molecular Determinants of Personalized Therapy

Volume:16   Issue: 2
Pp: 115-124
Antonio Lopez-Beltran, Matteo Santoni, Francesco Massari, Chiara Ciccarese, Giampaolo Tortora, Liang Cheng, Holger Moch, Marina Scarpelli, Carlos Reymundo and Rodolfo Montironi
DOI: 10.2174/1389450116666150204115756
Published on: 09 February, 2015

Oncotargets in Different Renal Cancer Subtypes

Volume:16   Issue: 2
Pp: 125-135
Holger Moch, Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng and Axel Mischo
DOI: 10.2174/1389450116666150126110632
Published on: 09 February, 2015

Drug Nanocrystals: Four Basic Prerequisites for Formulation Development and Scale-Up

Volume:16   Issue: 2
Pp: 136-147
Kale Mohana Raghava Srivalli and Brahmeshwar Mishra
DOI: 10.2174/1389450115666141120114036
Published on: 09 February, 2015

Targeting Drugs to APJ Receptor: The Prospect of Treatment of Hypertension and Other Cardiovascular Diseases

Volume:16   Issue: 2
Pp: 148-155
Jiangang Cao, Hening Li and Linxi Chen
DOI: 10.2174/1389450115666141128120053
Published on: 09 February, 2015

ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment

Volume:16   Issue: 2
Pp: 156-163
Amrita Devi Khwairakpam, Mayengbam Singh Shyamananda, Bethsebie Lalduhsaki Sailo, Sivakumar Raju Rathnakaram, Ganesan Padmavathi, Jibon Kotoky and Ajaikumar B. Kunnumakkara
DOI: 10.2174/1389450115666141224125117
Published on: 09 February, 2015

Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis

Volume:16   Issue: 2
Pp: 164-170
Roberto Iacovelli, Cora N. Sternberg, Camillo Porta, Elena Verzoni, Filippo de Braud, Bernard Escudier and Giuseppe Procopio
DOI: 10.2174/1389450115666141120120145
Published on: 09 February, 2015

Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments

Volume:16   Issue: 2
Pp: 171-178
Girolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, Luca Gallelli, Rosa Terracciano and Rosario Maselli
DOI: 10.2174/1389450116666141219122157
Published on: 09 February, 2015